1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014

SUMMARY
DelveInsight’s,“ Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vancomycin-Resistant Enterococcus Faecium Infections. This report provides information on the therapeutic development based on the Vancomycin-Resistant Enterococcus Faecium Infections dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Vancomycin-Resistant Enterococcus Faecium Infections
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Vancomycin-Resistant Enterococcus Faecium Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Vancomycin-Resistant Enterococcus Faecium Infections and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Vancomycin-Resistant Enterococcus Faecium Infections
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Vancomycin-Resistant Enterococcus Faecium Infections pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014
Table of Contents
- Vancomycin-Resistant Enterococcus Faecium Infections Overview
- Vancomycin-Resistant Enterococcus Faecium Infections Pipeline Therapeutics
- Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics under Development by Companies
- Vancomycin-Resistant Enterococcus Faecium Infections Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Vancomycin-Resistant Enterococcus Faecium Infections Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Vancomycin-Resistant Enterococcus Faecium Infections Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Vancomycin-Resistant Enterococcus Faecium Infections Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Vancomycin-Resistant Enterococcus Faecium Infections - Discontinued Products
- Vancomycin-Resistant Enterococcus Faecium Infections - Dormant Products
- Companies Involved in Therapeutics Development for Vancomycin-Resistant Enterococcus Faecium Infections
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Vancomycin-Resistant Enterococcus Faecium Infections, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Monotherapy Products
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Combination Products
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Route of Administration
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Stage and Route of Administration
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Molecule Type
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Stage and Molecule Type
- Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics - Discontinued Products
- Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Vancomycin-Resistant Enterococcus Faecium Infections, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Monotherapy Products
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Combination Products
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Route of Administration
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Stage and Route of Administration
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Molecule Type
- Vancomycin-Resistant Enterococcus Faecium Infections Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 4.73 billion by 2021 from USD 3.77 billion in 2016. The growth of this market ...

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance Summary The antibacterial drug market covers ...

Methicillin-resistant Staphylococcus aureus (MRSA) - Market Insights, Epidemiology and Market Forecast-2023

Methicillin-resistant Staphylococcus aureus (MRSA) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Methicillin-resistant Staphylococcus aureus (MRSA) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the ...

Global Feed Antibiotics Market

December 2016 $ 4250

Acetic Acid Markets In China

January 2017 $ 4000

Download Unlimited Documents from Trusted Public Sources

Anti-Infective and Therapy Market in Denmark

  • March 2017
    169 pages
  • Anti-Infective  

    Therapy  

    Dermatological ...  

  • Denmark  

View report >

Anti-Infective Market in the US - Forecast

  • March 2017
    8 pages
  • Anti-Infective  

  • United States  

    United Kingdom  

View report >

Anti-Infective Market in Sudan

  • February 2017
    8 pages
  • Anti-Infective  

  • Sudan  

View report >

Related Market Segments :

Anti-Infective

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.